Previous close | 178.82 |
Open | 177.60 |
Bid | 179.91 x 800 |
Ask | 180.10 x 1000 |
Day's range | 177.10 - 180.28 |
52-week range | 130.92 - 199.00 |
Volume | |
Avg. volume | 831,840 |
Market cap | 18.958B |
Beta (5Y monthly) | 0.59 |
PE ratio (TTM) | 25.20 |
EPS (TTM) | 7.13 |
Earnings date | 03 May 2024 |
Forward dividend & yield | 2.20 (1.23%) |
Ex-dividend date | 28 Feb 2024 |
1y target est | 195.54 |
CME Group (CME) Q1 results reflect higher revenues and increased average daily volume in four of its six asset classes.
Nasdaq's (NDAQ) first-quarter performance is likely to have been driven by organic revenue growth, and strong Market Platforms businesses, data and listing service revenues and Adenza contributions.
A diverse product portfolio, increased volatility, as well as a strong market position are likely to have aided CME Group's (CME) performance in the first quarter.